Mural Oncology Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Mural Oncology stock has a target of 13, which predicts an increase of 238.98% from the current stock price of 3.84.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$13	$13	$13	$13
Change	+238.98%	+238.98%	+238.98%	+238.98%

* Price targets were last updated on Apr 4, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for Mural Oncology is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	May '24
Strong Buy	0
Buy	1
Hold	0
Sell	0
Strong Sell	0
Total	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Judah Frommer Morgan Stanley	Morgan Stanley	Buy Initiates $13	Buy	Initiates	$13	+238.98%	Apr 4, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-10.84

from -12.43

EPS Next Year

-4.91

from -10.84

Year	2021	2022	2023	2024	2025	2026
Revenue	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-
EPS	-	-11.37	-12.43	-10.84	-4.91	-2.44
EPS Growth	-	-	-	-	-	-
No. Analysts	-	-	-	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.